Anaemia of prematurity: pathophysiology and treatment
- PMID: 20817366
- PMCID: PMC2981681
- DOI: 10.1016/j.blre.2010.08.001
Anaemia of prematurity: pathophysiology and treatment
Abstract
Most infants with birth weight <1.0 kg are given multiple red blood cell (RBC) transfusions within the first few weeks of life. The anaemia of prematurity is caused by untimely birth occurring before placental iron transport and fetal erythropoiesis are complete, by phlebotomy blood losses taken for laboratory testing, by low plasma levels of erythropoietin due to both diminished production and accelerated catabolism, by rapid body growth and need for commensurate increase in red cell volume/mass, and by disorders causing RBC losses due to bleeding and/or hemolysis. RBC transfusions are the mainstay of therapy with recombinant human erythropoietin largely unused because it fails to substantially diminish RBC transfusion needs--despite exerting substantial erythropoietic effects on neonatal marrow.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest statement
None to declare.
References
-
- Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2008 national Vital Statistics Reports. Centers for Disease Control and Prevention. 2009;57:7.
-
- Maier RJ, Sonntag J, Walka MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr. 2000;136:220–224. - PubMed
-
- Sacher RA, Strauss RG, Luban NL, et al. Blood component therapy during the neonatal period: A national survey of red cell transfusion practices, 1985. Transfusion. 1990;30:271–276. - PubMed
-
- Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics. 2000;106:E19. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
